Search the webpage

President, Chief Executive Officer and Director

President, Chief Executive Officer and Director

ABOUT

Dr. Kalesnykas earned his Ph.D. in Neuroscience in 2005 from the University of Kuopio and completed several postdoctoral fellowships studying the pathophysiology of glaucoma and ocular gene therapy. He currently serves as an Adjunct Professor of Experimental Ophthalmology at University of Tampere, Finland.

In 2009, Dr. Kalesnykas was awarded the prestigious position of Finnish Academy Research Fellow, which he held until 2013. He was a visiting researcher at the Wilmer Eye Institute at The Johns Hopkins University from 2010-2011. In 2013, he founded Experimentica Ltd., which under his leadership has grown to become one of the leading preclinical CROs dedicated to drug discovery and development for ophthalmic disorders.

FOLLOW

LATEST NEWS

Experimentica Ltd. participates in ORBITAL, an EU Horizon 2020 Marie Sklodowska-Curie Innovative Training Network award

News
Experimentica Ltd. is pleased to announce its participation as beneficiary in EU Horizon 2020 Marie Sklodowska-Curie Innovative Training Network award ... Read More

A retinal organotypic model for ex vivo neuroprotection studies

News
A recently published study by Experimentica Ltd. and its collaborators from the University of Tampere, Finland, shows that when the ... Read More

Thank you for visiting us at ARVO 2019 conference

News
Created by Simon Kaja on   June 5, 2019   in category: News Thank you, everyone, for visiting our booth at ARVO 2019 in Vancouver, Canada, ... Read More

Subscribe to Our Newsletter!

We promise that no sales pitches will be attached to newsletter. And don't worry, we hate spammers too!